MMF-Panacea Biotec

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Mycophenolate mofetil 250mg

Available from:

InterPharma (NZ) Ltd

INN (International Name):

Mycophenolate mofetil 250 mg

Dosage:

250 mg

Pharmaceutical form:

Capsule

Composition:

Active: Mycophenolate mofetil 250mg Excipient: Croscarmellose sodium Gelatin   Indigo carmine Iron oxide red Iron oxide yellow Magnesium stearate Povidone Purified water Starch Titanium dioxide  

Units in package:

Blister pack, Aclar, 100 capsules

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Concord Biotech Limited

Therapeutic indications:

prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants. prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants. In the treated population, MMF improved survival in the first year after transplantation. prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.

Product summary:

Package - Contents - Shelf Life: Blister pack, Aclar - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, Triplex - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 100 capsules - 24 months from date of manufacture stored at or below 25°C

Authorization date:

2010-07-20